mononeuropathy: Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ischemia; traumatic injury; compression; connective tissue diseases; cumulative trauma disorders; and other conditions.
Other and unspecified mononeuropathies of lower limb
DOID EFO Endpoint Browser PheWeb
G6_MONOLOWOTHUNS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1033 |
4. Check minimum number of eventsNone |
1033 |
5. Include endpointsNone |
1033 |
6. Filter based on genotype QC (FinnGen only) |
1033 |
Control definitions (FinnGen only)
- Control exclude
- G6_NERPLEX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified mononeuropathies of lower limb
based on the number of shared cases.
Similar with more cases:
- Nerve, nerve root and plexus disorders
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6122 | 3829 | 2260 |
| Only index persons | 5614 | 3606 | 2008 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.11 | 0.06 |
| Only index persons | 0.11 | 0.13 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 51.76 | 52.07 | 51.23 |
| Only index persons | 50.93 | 51.59 | 49.75 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1033 | 708 | 325 |
| Unadjusted period prevalence (%) | 0.21 | 0.24 | 0.14 |
| Median age at first event (years) | 52.58 | 51.90 | 54.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 942
- Matched controls
- 9420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
3731.5
323.0
513
*
G57.9
ICD-10 Finland
Mononeuropathy of lower limb, unspecified
1789.5
282.0
260
*
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
2227.6
185.8
174
*
3557X
ICD-9 Finland
Mononeuritis of lower limb, Other mononeuritis of lower limb
+∞
172.3
160
*
G57.6
ICD-10 Finland
Lesion of plantar nerve
52.8
110.4
132
29
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
77.6
97.9
110
16
N03AX16
ATC
pregabalin; oral
4.9
94.0
397
1229
G56.0
ICD-10 Finland
Carpal tunnel syndrome
16.8
90.1
148
103
N03AX12
ATC
gabapentin; oral
5.4
81.1
282
686
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
47.3
77.2
94
22
ACC51
NOMESCO Finland
Release of median nerve
82.7
61.9
69
9
M77.4
ICD-10 Finland
Metatarsalgia
7.8
60.7
149
222
N02AX02
ATC
tramadol; systemic, rectal
3.1
58.9
516
2638
M79.6
ICD-10 Finland
Pain in limb
3.1
57.9
462
2206
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
76.0
56.9
64
9
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
4.0
45.9
208
621
M25.5
ICD-10 Finland
Pain in joint
3.0
45.4
353
1587
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.7
45.0
517
2945
N06AA09
ATC
amitriptyline; systemic
4.3
44.2
181
490
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.1
44.0
192
552
M01AH05
ATC
etoricoxib; oral
2.6
41.3
634
4167
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.4
38.5
153
399
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
52.4
37.9
45
9
XA402
NOMESCO Finland
ENMG
11.4
37.2
71
67
A02BC05
ATC
esomeprazole; systemic
2.4
35.8
463
2689
M01AB05
ATC
diclofenac; systemic, rectal
2.5
35.0
686
4893
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
181.5
34.0
35
*
M54.5
ICD-10 Finland
Low back pain
2.5
33.5
369
1952
M03BX02
ATC
tizanidine; oral
2.3
32.6
643
4509
M54.4
ICD-10 Finland
Lumbago with sciatica
3.1
32.3
204
770
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.7
31.6
256
1131
N02AJ06
ATC
codeine and paracetamol; systemic
2.3
31.2
390
2177
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.8
30.7
144
432
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
5.5
30.6
95
189
3558X
ICD-9 Finland
Mononeuritis of lower limb, unspecified
+∞
30.4
29
*
M01AE03
ATC
ketoprofen; systemic, rectal
2.3
30.1
410
2377
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.6
29.3
269
1271
M01AC06
ATC
meloxicam; systemic, rectal
2.2
29.2
410
2403
N06AX21
ATC
duloxetine; oral
3.5
29.0
146
464
M01AE02
ATC
naproxen; oral, rectal
2.2
28.6
573
3924
N02BE01
ATC
paracetamol; systemic, rectal
2.9
28.0
842
6993
ZXA00
NOMESCO Finland
Right side
2.4
27.1
297
1527
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.6
27.1
130
396
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
25.6
26.7
37
15
M02AA07
ATC
piroxicam; topical
2.1
26.0
405
2447
L17
ICPC
Foot/toe symptom/complaint
2.3
25.9
286
1474
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.8
24.3
108
308
R52.2
ICD-10 Finland
Other chronic pain
6.6
24.1
63
101
M20.1
ICD-10 Finland
Hallux valgus (acquired)
3.3
24.1
132
443
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
7.6
22.8
54
75
M70.6
ICD-10 Finland
Trochanteric bursitis
2.8
22.5
161
646
A02BC03
ATC
lansoprazole; oral
2.1
21.8
320
1851
M01AH01
ATC
celecoxib; oral (coxibs)
2.4
21.5
222
1091
M01AX17
ATC
nimesulide; oral
2.2
21.4
274
1490
M48.0
ICD-10 Finland
Spinal stenosis
2.9
21.1
138
524
R51.80
ICD-10 Finland
Headache
2.7
21.0
165
697
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
7.7
20.9
49
67
G57.0
ICD-10 Finland
Lesion of sciatic nerve
78.6
20.8
23
*
S18
ICPC
Laceration/cut
2.0
20.7
410
2655
A02BC02
ATC
pantoprazole; systemic
1.9
20.3
637
4875
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
20.1
197
937
ZXA05
NOMESCO Finland
Left side
2.1
20.1
269
1487
M03BC01
ATC
orphenadrine (citrate); systemic
2.2
20.0
247
1316
M89.0
ICD-10 Finland
Algoneurodystrophy
22.1
19.6
28
13
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
19.5
301
1758
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
19.5
353
2196
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.7
19.4
144
588
M01AH02
ATC
rofecoxib; oral
2.6
19.2
155
665
M54.1
ICD-10 Finland
Radiculopathy
5.6
19.2
57
108
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
18.7
19.2
29
16
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
19.2
427
2861
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
4.4
18.9
71
173
A02BA02
ATC
ranitidine; systemic
2.2
18.6
213
1092
L15
ICPC
Knee symptom/complaint
2.2
18.5
222
1160
M02AA10
ATC
ketoprofen; topical
2.3
18.2
186
903
N03AE01
ATC
clonazepam; systemic
3.9
18.1
76
206
J01DB01
ATC
cefalexin; oral
2.1
18.0
768
6419
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.4
17.2
159
732
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
5.1
17.2
55
114
R20.2
ICD-10 Finland
Paraesthesia of skin
3.5
16.9
83
256
J01MA02
ATC
ciprofloxacin; systemic
1.8
16.8
373
2465
N06AX16
ATC
venlafaxine; oral
2.5
16.7
148
664
9271
FHL
Hallux surgery
6.0
16.7
46
80
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
3.0
16.6
99
351
2401
FHL
Nerve exploration (includes biopsy and removal of local change)
91.7
16.6
18
*
L03
ICPC
Low back symptom/complaint
2.0
16.6
238
1336
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.6
16.6
132
561
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.3
16.2
61
150
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.4
16.2
82
260
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
16.0
221
1218
M54.6
ICD-10 Finland
Pain in thoracic spine
3.4
15.8
80
253
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
15.7
15
*
Z50.1
ICD-10 Finland
Other physical therapy
3.6
15.7
71
206
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
15.7
270
1621
L13
ICPC
Hip symptom/complaint
2.2
15.6
177
895
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
3.8
15.5
66
182
WX320
NOMESCO Finland
Spinalanesthesy
2.0
15.4
234
1338
H02AB06
ATC
prednisolone; systemic
1.8
15.3
437
3104
N02AA05
ATC
oxycodone; systemic
2.3
15.2
156
754
SPAT1153
SPAT
Removal of sutures
1.9
15.2
307
1948
X58
ICD-10 Finland
Exposure to other specified factors
2.4
15.2
134
601
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
23.8
15.1
21
9
G56.2
ICD-10 Finland
Lesion of ulnar nerve
14.2
15.1
25
18
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.4
15.1
74
229
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
8.7
15.1
32
38
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
14.9
174
891
J02AC01
ATC
fluconazole; systemic
1.8
14.8
404
2818
N05CF01
ATC
zopiclone; oral
1.8
14.7
320
2077
L08
ICPC
Shoulder symptom/complaint
2.1
14.7
194
1046
9476
FHL
Splitting of fascia or aponeurosis
15.7
14.4
23
15
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
14.4
445
3213
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
3.1
14.4
82
282
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
14.4
207
1156
N06AA10
ATC
nortriptyline; systemic
5.8
14.3
40
71
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
3.7
14.3
64
184
M01AX01
ATC
nabumetone; oral
3.9
14.1
58
155
H02BX01
ATC
methylprednisolone, combinations; systemic
3.4
14.1
70
219
G57.1
ICD-10 Finland
Meralgia paraesthetica
10.3
14.0
27
27
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.6
14.0
48
108
N03AX09
ATC
lamotrigine; oral
3.8
13.9
60
167
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.7
13.9
47
104
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.1
13.9
79
272
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
13.9
280
1764
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
5.9
13.7
38
67
R03AC02
ATC
salbutamol; inhalant
1.7
13.7
485
3628
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.5
13.7
114
495
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
13.7
87
322
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
13.7
131
609
G57.5
ICD-10 Finland
Tarsal tunnel syndrome
76.2
13.6
15
*
J01DA01
ATC
[U] cefalexin; systemic
1.7
13.6
577
4542
M01AX05
ATC
glucosamine; oral
1.9
13.6
216
1250
J01FF01
ATC
clindamycin; systemic
1.8
13.6
263
1631
G56.4
ICD-10 Finland
Causalgia
+∞
13.6
13
*
M01AE01
ATC
ibuprofen; systemic, rectal
2.1
13.5
832
7382
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
13.5
116
513
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
26.2
13.4
18
7
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
3.0
13.3
81
291
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
13.3
277
1759
M54.3
ICD-10 Finland
Sciatica
3.2
13.3
71
235
N06AX11
ATC
mirtazapine; oral
1.8
13.3
309
2035
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
13.2
176
947
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
2.3
13.2
124
573
M79.1
ICD-10 Finland
Myalgia
2.2
12.8
135
656
J01AA02
ATC
doxycycline; systemic
1.8
12.8
737
6286
7354A
ICD-9 Finland
Acquired deformities of toe, Other hammer toe (acquired)
14.3
12.8
21
15
G44.2
ICD-10 Finland
Tension-type headache
2.2
12.8
139
685
A02BC01
ATC
omeprazole; systemic
1.8
12.7
258
1621
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
7.2
12.6
30
43
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
4.8
12.5
41
88
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
12.5
244
1511
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
12.5
177
978
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
12.3
253
1592
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
12.3
100
429
R06.0
ICD-10 Finland
Dyspnoea
1.8
12.3
236
1455
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
12.2
448
3343
A03FA02
ATC
cisapride; oral, rectal
2.7
12.2
87
347
Z00.0
ICD-10 Finland
General medical examination
2.0
12.1
174
965
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
7.4
12.1
28
39
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
5.3
12.1
36
70
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
12.0
112
515
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
4.2
12.0
45
111
M20.2
ICD-10 Finland
Hallux rigidus
4.2
12.0
45
111
M01AB55
ATC
diclofenac, combinations; oral
2.8
12.0
79
301
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
11.9
277
1810
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
3.3
11.9
59
185
M54.2
ICD-10 Finland
Cervicalgia
2.9
11.9
72
258
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.6
11.8
85
340
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.5
11.8
97
419
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
11.7
81
317
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.7
364
2590
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.7
11.7
81
318
R01AD09
ATC
mometasone; nasal
1.6
11.7
413
3042
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.2
11.6
62
205
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
5.2
11.6
35
69
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.0
11.6
46
120
R05FA02
ATC
opium derivatives and expectorants; systemic
1.6
11.6
386
2795
35399
ICD-8 Finland
Sciatica
+∞
11.5
11
*
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
3.8
11.4
47
127
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
3.3
11.4
58
186
M77.1
ICD-10 Finland
Lateral epicondylitis
2.8
11.1
70
259
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.3
11.1
105
485
L28
ICPC
Limited function/disability (L)
2.0
11.0
157
867
S29
ICPC
Skin symptom/complaint other
2.0
11.0
162
904
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
11.0
362
2605
R52.9
ICD-10 Finland
Pain, unspecified
2.5
10.9
88
374
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.5
10.9
86
363
R35
ICD-10 Finland
Polyuria
2.9
10.9
67
243
1220
FHL
Arthroscopy
3.3
10.8
53
165
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.7
10.8
46
128
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
5.5
10.8
31
58
WZA90
NOMESCO Finland
Other doctors statement
1.8
10.8
213
1319
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
3.8
10.7
44
119
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
10.6
99
454
G54.0
ICD-10 Finland
Brachial plexus disorders
14.4
10.5
17
12
M76.9
ICD-10 Finland
Enthesopathy of lower limb, unspecified
6.3
10.5
27
44
G54.8
ICD-10 Finland
Other nerve root and plexus disorders
111.2
10.4
11
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
10.4
10
*
2404
FHL
Nerve dissection (obturator 9364, Morton 9273, nerve tympanicus 4162)
+∞
10.4
10
*
J01FA10
ATC
azithromycin; systemic
1.6
10.3
514
4081
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
10.3
243
1583
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.2
10.3
105
505
M09AX01
ATC
hyaluronic acid; parenteral
2.9
10.3
63
228
M01AG02
ATC
tolfenamic acid; oral, rectal
1.9
10.2
152
852
NBG10
NOMESCO Finland
Acromioplastia
4.6
10.1
34
76
J20
ICD-10 Finland
Acute bronchitis
2.2
10.0
105
507
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.5
10.0
77
321
UKC02
NOMESCO Finland
Cystoscopy
2.0
10.0
141
773
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.3
9.9
49
154
N04BC05
ATC
pramipexole; oral
2.5
9.9
79
335
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.1
9.9
53
177
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
9.8
92
423
WX002
NOMESCO Finland
Sedation and analgesia
1.8
9.8
184
1115
N03AF01
ATC
carbamazepine; oral, rectal
3.0
9.7
55
188
G57.2
ICD-10 Finland
Lesion of femoral nerve
55.6
9.7
11
*
TQW40
NOMESCO Finland
Remowal of suture of skin
2.5
9.6
77
326
M75
ICD-10 Finland
Shoulder lesions
3.4
9.6
46
142
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.4
9.5
82
360
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.2
9.5
49
160
G54.4
ICD-10 Finland
Lumbosacral root disorders, not elsewhere classified
+∞
9.4
9
*
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
9.4
9
*
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.2
9.3
101
498
R52.1
ICD-10 Finland
Chronic intractable pain
10.8
9.3
17
16
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
2.1
9.3
109
555
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
3.9
9.3
37
98
R06AE07
ATC
cetirizine; oral
1.6
9.3
387
2919
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
9.2
111
573
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.1
9.2
108
551
H02AB04
ATC
methylprednisolone; systemic
1.9
9.2
144
821
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
9.2
610
5118
M79.7
ICD-10 Finland
Fibromyalgia
3.4
9.1
43
131
ZXD20
NOMESCO Finland
Day surgery
2.0
9.1
122
656
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
9.1
297
2106
N05CD07
ATC
temazepam; oral
2.0
9.1
125
679
R03BA05
ATC
fluticasone; inhalant
1.8
9.1
167
1007
M01AH03
ATC
valdecoxib; oral
2.5
9.1
68
280
Z3226
NOMESCO Finland
Physiotherapist
1.8
9.0
165
990
N05BA04
ATC
oxazepam; oral
1.7
9.0
238
1592
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
3.2
9.0
45
144
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
5.3
9.0
26
50
K07.60
ICD-10 Finland
Snapping jaw
3.0
8.9
51
177
A01
ICPC
Pain general/multiple sites
2.3
8.9
79
355
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
8.9
192
1213
M19.9
ICD-10 Finland
Arthrosis, unspecified
3.2
8.9
44
140
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
6.7
8.7
21
32
M01AB51
ATC
indometacin, combinations; oral, rectal
4.4
8.7
30
70
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
3.0
8.7
49
168
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.5
8.7
68
285
WX110
NOMESCO Finland
Local anesthesy
1.5
8.7
597
5013
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.5
8.6
65
267
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
8.6
62
250
L16
ICPC
Ankle symptom/complaint
2.1
8.6
95
471
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
3.3
8.6
41
127
NH1AD
NOMESCO Finland
Ankle and foot CT
4.2
8.5
31
76
N05BA01
ATC
diazepam; systemic, rectal
1.9
8.5
125
697
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
8.5
488
3926
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
3.8
8.5
34
91
G51.0
ICD-10 Finland
Bell palsy
27.8
8.5
11
*
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
8.5
286
2038
XQ800
NOMESCO Finland
Prick test
2.3
8.5
74
331
AA1AD
NOMESCO Finland
CT of head and brain
1.7
8.5
206
1348
S83.2
ICD-10 Finland
Tear of meniscus, current
2.5
8.5
67
283
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
8.5
54
203
G58.9
ICD-10 Finland
Mononeuropathy, unspecified
90.8
8.4
9
*
35708
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Alterius nervi
+∞
8.3
8
*
NBE45
NOMESCO Finland
Plastic repair of ligament of shoulder not using prosthetic material, arthroscopic
8.6
8.3
17
20
S80.0
ICD-10 Finland
Contusion of knee
2.5
8.3
63
260
R01AD08
ATC
fluticasone; nasal
1.6
8.3
254
1764
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
9.6
8.3
16
17
P01AB01
ATC
metronidazole; oral, rectal
1.5
8.3
356
2682
9211
FHL
Exploration or removal of diskusprolapse
4.3
8.2
29
69
R05FB02
ATC
cough suppressants and expectorants
1.5
8.2
343
2570
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
8.2
83
396
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.2
8.1
29
70
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
3.7
8.1
34
95
L29
ICPC
Musculoskeletal sympt/complt other
2.3
8.1
73
330
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
33.6
8.1
10
*
A06AD11
ATC
lactulose; oral
1.9
8.1
121
678
TAC00
NOMESCO Finland
Peripheral nerve block
22.2
8.0
11
5
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
3.6
8.0
34
96
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.7
8.0
33
91
D07AD01
ATC
clobetasol; topical
1.8
8.0
143
851
T93.2
ICD-10 Finland
Sequelae of other fractures of lower limb
7.3
8.0
18
25
R32
ICD-10 Finland
Unspecified urinary incontinence
3.5
8.0
36
107
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.3
8.0
38
118
L02
ICPC
Back symptom/complaint
2.2
8.0
84
408
UJF32
NOMESCO Finland
Coloscopy
1.6
7.9
226
1541
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
7.9
129
745
R30.1
ICD-10 Finland
Vesical tenesmus
4.6
7.9
26
58
R05
ICD-10 Finland
Cough
1.7
7.8
175
1115
M65.3
ICD-10 Finland
Trigger finger
3.2
7.8
39
125
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
4.2
7.8
28
68
R5599
NOMESCO Finland
Other rehabilitation service
3.9
7.8
30
78
J01FA09
ATC
clarithromycin; systemic
1.6
7.8
276
1982
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
7.8
64
279
R07.0
ICD-10 Finland
Pain in throat
2.5
7.8
57
233
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
5.1
7.8
23
46
M01AB01
ATC
indometacin; systemic, rectal
2.3
7.7
71
325
J01FA06
ATC
roxithromycin; oral
1.5
7.7
364
2787
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.5
7.7
60
253
B01AB05
ATC
enoxaparin; parenteral
1.5
7.7
275
1981
M22.4
ICD-10 Finland
Chondromalacia patellae
3.5
7.7
34
100
R07.3
ICD-10 Finland
Other chest pain
2.1
7.7
87
439
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
7.6
199
1322
NHM10
NOMESCO Finland
Fasciotomy of ankle or foot
8.1
7.6
16
20
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
7.6
72
333
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
7.6
241
1685
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
7.5
157
980
M67.8
ICD-10 Finland
Other specified disorders of synovium and tendon
7.2
7.5
17
24
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
4.9
7.5
23
48
J01CA04
ATC
amoxicillin; systemic
1.5
7.5
702
6196
J02AC02
ATC
itraconazole; systemic
1.7
7.4
165
1049
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.2
7.4
71
330
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.2
7.4
76
366
G50.1
ICD-10 Finland
Atypical facial pain
7.7
7.4
16
21
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.6
7.4
54
218
L01
ICPC
Neck symptom/complaint
1.8
7.4
123
716
R60.0
ICD-10 Finland
Localized oedema
1.9
7.4
103
563
E0000UV
ATC
NA
1.5
7.3
336
2550
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.0
7.3
93
492
3556A
ICD-9 Finland
Mononeuritis of lower limb, Lesion of plantar nerve
+∞
7.3
7
*
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.5
7.3
55
230
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.6
7.2
31
89
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
4.7
7.2
23
50
A02BC04
ATC
rabeprazole; oral
2.1
7.2
79
390
N05CF02
ATC
zolpidem; oral
1.7
7.2
157
991
R4120
NOMESCO Finland
Occupational therapy
2.4
7.2
57
243
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
7.2
373
2901
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
3.9
7.2
28
74
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
7.2
478
3913
6262A
ICD-9 Finland
Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]
3.5
7.2
32
95
N03AF02
ATC
oxcarbazepine; oral
3.5
7.2
32
95
L84
ICD-10 Finland
Corns and callosities
3.2
7.2
36
117
R05
ICPC
Cough
1.6
7.1
196
1320
9473
FHL
Local soft tissue removal or exploration (eg Bursa)
6.6
7.1
17
26
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
7.1
93
495
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
4.1
7.1
26
65
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
4.1
7.1
26
65
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.4
7.1
56
238
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
6.1
7.1
18
30
SPAT1229
SPAT
Assessment of need for aid
2.1
7.1
74
360
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
7.0
143
886
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
7.0
35
113
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
7.0
100
550
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
7.0
43
160
L86
ICPC
Back syndrome with radiating pain
2.5
7.0
53
222
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
6.4
7.0
17
27
TAB20
NOMESCO Finland
Epidural puncture
6.4
7.0
17
27
A03CA02
ATC
clidinium and psycholeptics; oral
2.3
6.9
63
287
L90
ICPC
Osteoarthrosis of knee
2.3
6.9
60
266
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.3
6.9
61
276
C10AA07
ATC
rosuvastatin; oral
1.6
6.9
207
1423
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
5.4
6.8
19
36
R01AD01
ATC
beclometasone; nasal
1.7
6.8
137
846
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.6
6.7
45
176
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
3.1
6.7
35
117
F45.8
ICD-10 Finland
Other somatoform disorders
2.3
6.7
60
273
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
7.2
6.7
15
21
M23.8
ICD-10 Finland
Other internal derangements of knee
2.9
6.7
38
133
M76.7
ICD-10 Finland
Peroneal tendinitis
6.5
6.7
16
25
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
6.6
115
678
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
6.6
108
625
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
4.1
6.6
24
60
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
4.1
6.6
24
60
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
6.6
134
827
F51.0
ICD-10 Finland
Nonorganic insomnia
1.8
6.6
109
630
M13.9
ICD-10 Finland
Arthritis, unspecified
2.1
6.6
68
329
9481
FHL
Detachment or severance of a muscle or tendon
12.3
6.6
11
9
G50.0
ICD-10 Finland
Trigeminal neuralgia
8.8
6.6
13
15
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.6
6.5
27
76
N05AH04
ATC
quetiapine; oral
1.7
6.5
130
798
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
5.1
6.5
19
38
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
3.7
6.5
26
71
WX212
NOMESCO Finland
Femoral plexus blockade
4.5
6.5
21
47
NHG82
NOMESCO Finland
Fusion of other tarsal joint
5.4
6.5
18
34
N64.4
ICD-10 Finland
Mastodynia
3.4
6.5
29
87
G43.9
ICD-10 Finland
Migraine, unspecified
2.5
6.5
47
193
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
5.7
6.5
17
30
J31.0
ICD-10 Finland
Chronic rhinitis
2.1
6.5
70
348
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
4.3
6.4
22
52
M54
ICD-10 Finland
Dorsalgia
1.8
6.4
101
576
S94.3
ICD-10 Finland
Injury of cutaneous sensory nerve at ankle and foot level
70.3
6.4
7
*
G56.8
ICD-10 Finland
Other mononeuropathies of upper limb
70.3
6.4
7
*
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
2.8
6.4
38
138
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.4
6.4
443
3624
S22.3
ICD-10 Finland
Fracture of rib
2.3
6.4
58
266
7352A
ICD-9 Finland
Acquired deformities of toe, Hallux rigidus
14.4
6.4
10
7
WX308
NOMESCO Finland
Sacral anesthesy
14.4
6.4
10
7
N07BC02
ATC
methadone; systemic
14.4
6.4
10
7
XF402
NOMESCO Finland
ECG with work load test
1.8
6.3
105
608
NG2AA
NOMESCO Finland
Patella X-ray examination
3.3
6.3
29
89
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
3.7
6.3
25
68
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
11.1
6.3
11
10
NHA30
NOMESCO Finland
Exploration of joint of ankle or foot, arthroscopic
9.3
6.3
12
13
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.6
6.3
169
1130
N02AC04
ATC
dextropropoxyphene; oral
2.8
6.3
37
134
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.0
6.3
81
431
SPAT1211
SPAT
Application of soft bandage
2.0
6.3
77
402
AEA20
NOMESCO Finland
Removal of impulse generator of stimulation device in the nervous system
18.1
6.3
9
5
ACB99
NOMESCO Finland
Other operation for lesion of peripheral nerve: other or unspecified
+∞
6.3
6
*
ACA19
NOMESCO Finland
Exploration of peripheral nerve other or unspecified
+∞
6.3
6
*
G58.8
ICD-10 Finland
Other specified mononeuropathies
+∞
6.3
6
*
L14
ICPC
Leg/thigh symptom/complaint
2.1
6.2
68
338
M19.8
ICD-10 Finland
Other specified arthrosis
2.8
6.2
37
135
R60.9
ICD-10 Finland
Oedema, unspecified
2.5
6.2
45
185
Z3231
NOMESCO Finland
Registered nurse
1.5
6.2
225
1618
WX702
NOMESCO Finland
Supraglottic ventilation device
2.5
6.2
47
197
I20.09
ICD-10 Finland
Unstable angina
2.4
6.2
48
205
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
6.2
433
3541
XQ802
NOMESCO Finland
Epicutan test
2.7
6.1
38
143
R06.5
ICD-10 Finland
Mouth breathing
2.0
6.1
70
356
Z47.8
ICD-10 Finland
Other specified orthopaedic follow-up care
7.7
6.1
13
17
L60.0
ICD-10 Finland
Ingrowing nail
2.7
6.1
40
154
H02.3
ICD-10 Finland
Blepharochalasis
2.1
6.1
63
307
L12
ICPC
Hand/finger symptom/complaint
1.7
6.1
115
694
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
6.1
73
375
T78.4
ICD-10 Finland
Allergy, unspecified
2.6
6.1
41
162
NH3BG
NOMESCO Finland
MRI of foot
8.7
6.1
12
14
NHG22
NOMESCO Finland
Fusion of subtalar joint
8.7
6.1
12
14
D07AC13
ATC
mometasone; topical
1.5
6.0
245
1799
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
6.0
373
2978
G04CA02
ATC
tamsulosin; oral
1.7
6.0
132
836
K59.1
ICD-10 Finland
Functional diarrhoea
2.4
6.0
49
213
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013707) Erythrocyte sedimentation rate by Westergren method
787
6334
2.02
20.21
5.5
3.9
mm/h
11.7
12.4
0.87
720
5819
(3013115) Eosinophils [#/volume] in Blood
582
4315
1.80
18.58
6.5
5.8
e9/l
0.2
0.2
0.35
513
3778
(42870588) Differential panel, method unspecified - Blood
413
2797
1.79
17.66
6.5
5.5
—
—
—
0
0
(3019225) pH of Specimen
166
832
2.19
17.18
4.0
3.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
558
4185
1.72
16.20
6.4
5.5
e9/l
0.0
0.0
1.04
495
3614
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
521
3848
1.71
15.88
6.2
5.4
mmol/l
1.2
1.2
0.72
441
3475
(3001604) Monocytes [#/volume] in Blood
554
4166
1.71
15.76
6.4
5.5
e9/l
0.6
0.6
0.15
493
3598
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
794
6633
1.85
15.31
7.4
7.2
u/l
76.2
78.5
0.94
733
6230
(3019198) Lymphocytes [#/volume] in Blood
563
4274
1.70
15.27
6.5
5.5
e9/l
2.0
1.9
0.60
506
3749
(3019069) Monocytes/100 leukocytes in Blood
526
3936
1.69
14.94
7.3
5.9
%
8.3
8.6
1.69
484
3675
(3006504) Eosinophils/100 leukocytes in Blood
524
3918
1.68
14.92
6.9
5.6
%
2.9
2.8
0.34
478
3642
(3002030) Lymphocytes/100 leukocytes in Blood
535
4032
1.68
14.70
7.0
5.7
%
27.8
27.7
0.07
486
3747
(3018010) Neutrophils/100 leukocytes in Blood
529
3978
1.68
14.63
6.7
5.5
%
57.2
57.4
0.15
480
3711
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
193
1084
1.96
14.54
5.2
4.4
%
31.0
32.4
0.95
105
713
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
367
2520
1.71
14.21
2.5
2.0
u/l
194.1
230.3
0.33
341
2368
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
552
4225
1.66
14.04
5.6
6.2
mmol/l
1.2
1.2
1.21
460
3556
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
517
3894
1.66
13.98
4.1
3.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
710
5819
1.70
13.71
5.6
4.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
506
3812
1.64
13.51
7.0
5.6
%
0.7
0.7
0.02
459
3543
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
470
3511
1.62
12.73
2.2
1.9
pmol/l
100.4
96.0
1.26
223
1750
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
945
8519
2.28
12.73
18.3
13.3
mg/l
21.0
23.6
1.73
787
6672
(3013650) Neutrophils [#/volume] in Blood by Automated count
616
4933
1.62
12.38
8.2
8.9
e9/l
4.2
4.1
0.33
539
4319
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
180
1041
1.88
12.28
7.5
6.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
183
1072
1.86
11.97
1.5
1.3
titre
486.5
595.0
0.32
43
232
(3021960) Folate [Moles/volume] in Serum or Plasma
294
1979
1.68
11.86
1.5
1.5
nmol/l
23.4
21.1
0.57
234
1683
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
474
3607
1.58
11.51
2.5
2.2
nmol/l
78.3
78.6
0.06
408
3227
(3007164) IgA [Mass/volume] in Serum or Plasma
241
1558
1.71
11.22
1.5
1.4
g/l
2.3
2.5
0.51
124
945
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
269
1793
1.68
11.17
1.3
1.2
u/ml
2.9
1.7
0.30
47
482
(3013826) Glucose [Moles/volume] in Serum or Plasma
602
4859
1.57
11.16
5.1
4.4
mmol/l
6.6
6.7
0.24
569
4536
(3044640) Blood type and Crossmatch panel - Blood
366
2645
1.59
10.94
2.6
2.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
278
1879
1.66
10.90
1.8
1.6
mg/l
1.1
1.2
0.15
208
1425
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
424
3181
1.56
10.73
4.4
3.5
ng/l
22.6
45.4
1.29
289
2198
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
360
2601
1.59
10.72
2.9
2.3
u/l
58.5
57.3
0.14
316
2388
(3031040) Bacteria [#/volume] in Urine by Automated count
670
5589
1.57
10.37
5.8
4.4
e6/l
3261.6
1971.2
0.15
14
89
(3013512) EKG study
346
2504
1.57
10.11
4.4
3.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
550
4423
1.52
9.83
4.9
6.1
umol/l
10.4
11.3
1.71
503
4194
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
290
2029
1.60
9.73
2.5
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
212
1384
1.67
9.35
1.3
1.2
u/ml
10.7
14.3
0.27
63
550
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
770
6703
1.58
9.25
4.6
4.0
pmol/l
14.8
14.8
0.16
686
6060
(40768797) Stomach Pathology biopsy report
191
1218
1.70
9.19
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
154
925
1.78
9.16
2.0
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
455
3561
1.50
8.98
2.9
2.6
ug/l
110.2
126.2
0.92
411
3257
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
882
7965
1.73
8.89
5.7
4.8
mu/l
1.9
2.1
0.33
790
7258
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
333
2457
1.52
8.65
3.6
2.8
ng/l
1033.1
1150.2
0.35
267
2067
(3023103) Potassium [Moles/volume] in Serum or Plasma
961
8934
2.09
8.52
19.6
15.4
mmol/l
4.0
4.0
1.62
934
8684
(3019550) Sodium [Moles/volume] in Serum or Plasma
959
8909
2.07
8.51
19.8
15.3
mmol/l
139.6
139.7
0.40
932
8671
(40761511) CBC panel - Blood by Automated count
960
8936
2.05
8.25
17.4
12.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
425
3329
1.47
8.11
7.5
8.8
inr
1.2
1.2
0.49
100
965
(36660697) Celiac disease serology panel - Serum
110
622
1.86
7.95
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
230
1604
1.56
7.59
1.7
1.7
nmol/l
1275.5
1240.6
0.17
157
1182
(3022217) INR in Platelet poor plasma by Coagulation assay
164
1065
1.64
7.27
16.5
25.1
inr
1.1
1.3
0.87
17
144
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
644
5539
1.43
7.02
3.4
3.0
u/l
48.2
48.4
0.02
585
5129
(3024561) Albumin [Mass/volume] in Serum or Plasma
449
3658
1.40
6.48
4.1
4.5
g/l
35.7
35.6
0.16
408
3398
(3000494) Fungus identified in Specimen by Culture
152
997
1.62
6.45
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
205
1453
1.51
6.18
1.4
1.2
iu/ml
19.9
36.0
3.07
62
487
(3045414) Leukocytes [Presence] in Urine
67
351
1.97
6.11
2.0
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
54
264
2.10
5.94
2.1
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
868
7999
1.53
5.89
6.5
5.6
mmol/mol
39.6
39.6
0.04
777
7395
(3009343) pH of Capillary blood
88
512
1.79
5.82
3.4
3.1
ph
7.4
7.4
—
10
65
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
85
490
1.80
5.80
3.2
3.1
mmol/l
2.1
1.8
0.37
69
369
(3022948) Iron [Moles/volume] in Serum or Plasma
177
1237
1.52
5.67
2.3
2.2
umol/l
12.8
13.1
0.29
163
1146
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
88
517
1.77
5.64
3.4
3.1
kpa
5.2
5.1
0.59
83
480
(3019150) Specific gravity of Urine by Refractometry
240
1795
1.44
5.45
5.0
4.0
kg/l
1.0
1.0
0.28
30
248
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
89
2.85
5.43
1.1
1.3
nmol/l
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
91
546
1.73
5.42
3.2
3.2
e9/l
3.8
4.0
0.35
60
418
(3026493) Urate [Moles/volume] in Serum or Plasma
277
2133
1.41
5.34
2.4
2.4
umol/l
1926.9
6656.7
1.82
236
1855
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
46
221
2.13
5.32
1.6
1.2
u/ml
1.6
5.7
—
5
42
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
338
2693
1.38
5.31
2.8
3.1
u/l
28.1
31.7
2.54
320
2561
(40768804) Tissue Pathology biopsy report
429
3557
1.35
5.21
2.1
2.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
97
2.72
5.20
1.3
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
267
2057
1.40
5.10
2.4
2.1
mg/l
2.9
3.0
0.67
219
1741
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
147
2.36
5.05
1.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
106
676
1.63
5.04
4.3
3.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
26
99
2.67
5.01
1.3
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
161
1132
1.50
4.99
2.4
2.2
g/l
2.4
2.3
0.29
150
1050
(3005322) IgE [Units/volume] in Serum or Plasma
83
498
1.72
4.96
1.4
1.3
u/ml
84.2
195.0
3.20
77
452
(4010399)
99
623
1.65
4.96
1.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
847
7838
1.45
4.92
17.7
14.6
%
39.5
39.6
0.03
572
5559
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
26
100
2.64
4.92
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
26
100
2.64
4.92
1.3
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
163
1153
1.49
4.91
2.4
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
141
969
1.53
4.87
1.9
2.3
ug/g
95.9
129.4
1.05
95
765
(3036481) Cortisol [Moles/volume] in Serum or Plasma
110
716
1.60
4.82
1.9
2.0
nmol/l
386.1
381.5
0.09
91
656
(3021788) Differential panel - Synovial fluid
32
138
2.36
4.79
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
97
2.62
4.66
1.4
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
65
372
1.80
4.58
3.2
3.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
993
9560
2.00
4.58
26.3
19.9
e9/l
255.8
253.1
0.69
969
9298
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
98
2.59
4.57
1.4
1.3
—
—
—
0
0
(4146454)
22
81
2.75
4.53
3.4
2.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
993
9563
1.99
4.53
26.2
19.8
fl
91.4
91.2
0.82
977
9416
(3035941) MCH [Entitic mass]
993
9565
1.99
4.49
26.2
19.8
pg
30.4
30.3
0.70
977
9416
(3026361) Erythrocytes [#/volume] in Blood
993
9566
1.98
4.47
26.3
19.9
e12/l
4.4
4.5
0.91
966
9279
(3010813) Leukocytes [#/volume] in Blood
993
9567
1.98
4.46
26.3
19.9
e9/l
6.9
6.6
1.91
966
9275
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
963
9196
1.70
4.44
12.2
10.1
u/l
25.5
25.4
0.03
910
8875
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
150
1065
1.48
4.43
2.4
2.3
%
22.2
23.0
0.29
119
912
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
37
176
2.14
4.43
1.4
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
363
2991
1.33
4.42
2.5
3.4
mmol/l
2.4
2.4
0.10
277
2603
(3000963) Hemoglobin [Mass/volume] in Blood
993
9569
1.97
4.42
26.4
20.0
g/l
133.9
134.5
0.68
978
9418
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
879
8231
1.46
4.42
15.9
12.5
ml/min/173m2
80.0
79.7
0.17
720
6776
(3019060) Gas panel - Arterial blood
81
500
1.67
4.39
7.0
4.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
30
132
2.31
4.32
1.4
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
249
1944
1.37
4.31
4.6
3.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
61
2.99
4.29
2.3
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
31
3.90
4.26
1.2
2.3
ug/l
20.0
287.6
0.48
12
26
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
114
2.41
4.26
1.2
2.5
mg/l
11.6
31.6
—
5
32
(3004616) Nuclear Ab [Presence] in Serum
23
92
2.53
4.07
1.6
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
98
648
1.57
4.04
3.1
3.4
ng/l
71.0
85.5
1.97
78
561
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
173
1284
1.42
4.03
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
84
536
1.62
4.01
3.9
2.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
271
2168
1.34
3.97
6.7
6.5
—
—
—
0
0
(3015736) pH of Urine
384
3227
1.30
3.96
4.0
3.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
251
3109
0.75
3.94
3.0
2.9
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
36
180
2.04
3.82
1.6
1.5
e6/l
15464.9
17311.0
0.11
30
132
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
895
8467
1.43
3.70
5.2
4.5
mmol/l
5.9
5.9
0.21
796
7675
(3009261) Glucose [Presence] in Urine by Test strip
487
4247
1.28
3.69
4.4
3.6
estimate
0.0
0.0
0.39
63
755
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
24
103
2.36
3.68
1.1
1.3
nmol/l
0.6
0.6
0.06
24
97
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
88
585
1.55
3.56
1.6
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
71
449
1.62
3.54
2.7
2.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
482
4213
1.27
3.54
5.7
5.0
estimate
0.0
0.0
0.50
67
765
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
55
325
1.73
3.53
1.4
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
96
652
1.52
3.53
1.6
2.6
g/l
66.4
67.0
0.43
86
595
(3023368) Bacteria identified in Blood by Culture
267
2166
1.31
3.51
4.3
4.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
477
4170
1.27
3.48
4.3
3.6
estimate
0.0
0.0
0.00
61
766
(3013139) Helicobacter pylori Ag [Presence] in Stool
84
558
1.55
3.42
1.3
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
20
83
2.44
3.32
346.8
5.4
mmol/l
7.2
7.3
0.07
15
67
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
202
1589
1.34
3.27
5.1
3.5
ng/l
289.5
360.7
0.12
154
1226
(40768443) Skin Pathology biopsy report
60
373
1.65
3.22
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
226
1814
1.31
3.18
1.5
1.7
pmol/l
128415729.5
28913627.5
0.71
183
1463
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
100
702
1.47
3.15
2.0
2.4
ug/l
7.2
7.1
0.01
76
616
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
39
216
1.84
3.13
1.4
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
903
8606
1.39
3.11
4.9
4.4
mmol/l
4.7
4.7
0.18
812
7925
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
174
1350
1.35
3.09
2.1
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
188
1.89
3.09
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
34
181
1.91
3.08
2.7
2.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
112
2.17
3.08
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
897
8543
1.38
3.07
5.0
4.3
mmol/l
1.5
1.5
0.76
807
7823
(3026008) Bacteria identified in Urine by Culture
319
2689
1.27
3.06
3.6
3.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
255
1.76
3.06
1.4
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
45
2.91
3.03
1.2
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
44
256
1.75
3.02
1.8
2.3
g/l
0.7
1.2
0.37
34
218
(3014271) Vancomycin [Susceptibility]
12
40
3.02
2.98
3.3
2.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
55
343
1.64
2.94
2.3
2.1
u/l
34.7
40.1
1.29
49
299
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
917
8777
1.40
2.93
5.4
4.9
mmol/l
2.8
2.8
0.31
821
8042
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
20
89
2.27
2.88
1.2
1.4
%
40.3
63.9
1.25
13
60
(3009508) Creatinine [Moles/volume] in Urine
306
2590
1.26
2.81
3.3
3.0
mmol/l
7.3
7.2
0.13
234
2175
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
15
60
2.52
2.71
1.6
1.1
—
2.0
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
112
2.08
2.68
1.5
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
40
236
1.72
2.65
1.6
2.0
g/l
38.4
37.3
0.56
31
197
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
81
566
1.47
2.65
1.2
1.2
iu/ml
190.6
140.3
0.31
26
223
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
49
306
1.63
2.63
2.3
1.8
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
15
61
2.48
2.62
1.2
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
283
1.65
2.62
1.5
2.1
g/l
8.9
10.5
2.91
35
236
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
299
1.63
2.61
1.7
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
299
1.63
2.61
1.7
2.1
g/l
7.4
7.4
0.00
32
218
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
299
1.63
2.61
1.7
2.1
g/l
3.5
3.8
1.11
31
209
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
11
38
2.92
2.58
1.2
1.0
—
7.5
—
0
5
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
38
2.92
2.58
1.1
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
31
171
1.84
2.56
1.5
1.2
u/ml
75.8
20.3
—
5
18
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
56
2.52
2.53
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
56
2.52
2.53
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
56
2.52
2.53
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
94
682
1.42
2.53
3.0
2.8
ng/l
125.4
200.4
2.39
78
629
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
122
1.99
2.52
1.4
1.8
g/l
0.4
0.9
2.33
19
93
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
122
928
1.36
2.48
2.5
2.6
umol/l
9.4
8.5
0.12
103
813
(3012095) Magnesium [Moles/volume] in Serum or Plasma
165
1313
1.31
2.46
3.1
3.1
mmol/l
0.8
0.8
0.27
153
1228
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
57
2.48
2.45
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
57
2.48
2.45
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
57
2.48
2.45
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
306
2625
1.24
2.45
4.1
3.8
mg/mmol
5.3
7.6
0.81
174
1602
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
96
2.10
2.44
1.1
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
135
1047
1.33
2.42
4.4
4.8
mmol/l
1.0
1.0
0.10
121
955
(3023419) Bacteria identified in Sputum by Culture
21
104
2.04
2.37
2.0
2.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
276
1.62
2.35
1.7
2.2
g/l
3.1
3.1
0.05
32
215
(3000570) Elastase.pancreatic [Mass/mass] in Stool
39
238
1.66
2.32
1.2
1.5
ug/g
273.3
299.8
0.24
19
133
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
51
333
1.56
2.31
2.5
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
865
8268
1.28
2.31
4.5
3.9
mmol/l
1.3
1.3
1.17
772
7524
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
554
5064
1.20
2.28
3.0
2.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
252
2133
1.24
2.26
4.1
3.6
%
92.0
91.3
0.16
247
2075
(3003327) Ova and parasites identified in Stool by Light microscopy
40
248
1.64
2.24
1.5
1.6
—
—
—
0
0
(44790049)
18
86
2.11
2.23
1.2
1.6
—
—
—
0
0
(44790048)
18
86
2.11
2.23
1.2
1.6
—
—
—
0
0
(44790047)
18
86
2.11
2.23
1.2
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
48
2.52
2.19
1.1
1.6
ug/l
5.9
8.7
0.60
12
41
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
73
522
1.43
2.15
1.9
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
40
251
1.62
2.15
2.7
2.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
66
465
1.45
2.11
1.3
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
10
5.02
2.07
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
10
5.02
2.07
1.0
1.1
%
107.2
93.8
—
5
10
(3004588) Protein electrophoresis panel - Serum or Plasma
76
552
1.41
2.07
1.6
2.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
18
89
2.04
2.06
1.3
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
20
3.52
2.05
2.0
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
20
3.52
2.05
2.0
2.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
56
2.34
2.05
1.3
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
120
939
1.31
2.04
1.8
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
121
948
1.31
2.04
1.3
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
15
4.02
2.04
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
45
296
1.54
2.01
2.3
2.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
114
889
1.32
1.99
7.9
7.4
kpa
12.1
12.3
0.19
109
856
(3003396) Base excess in Arterial blood by calculation
114
890
1.32
1.97
8.1
7.4
mmol/l
1.5
1.1
0.68
97
710
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
120
946
1.30
1.94
1.9
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
155
1264
1.27
1.93
1.8
1.9
s
29.9
29.5
0.37
148
1224
(3018418) pH of Serum or Plasma
293
2558
1.20
1.92
3.4
3.7
ph
7.4
7.4
0.44
38
490
(3021879) Hepatitis B virus core Ab [Presence] in Serum
70
510
1.40
1.89
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
103
798
1.32
1.89
1.4
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
65
2.17
1.88
1.2
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
22
3.20
1.88
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
22
3.20
1.88
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
22
3.20
1.88
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
22
3.20
1.88
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
283
2468
1.20
1.87
3.5
3.2
mg/l
627.7
294.0
0.36
165
1507
(44806118)
17
86
1.99
1.85
1.2
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
43
286
1.53
1.85
1.1
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
123
981
1.29
1.83
1.4
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
60
430
1.42
1.79
3.2
3.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
111
877
1.30
1.78
1.9
1.7
%
1.4
1.5
0.32
96
764
(3027945) Reticulocytes/100 erythrocytes in Blood
113
896
1.29
1.77
2.0
2.5
%
1.8
1.8
0.04
98
803
(3029075) Extractable nuclear Ab panel - Serum
7
24
2.93
1.72
1.3
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
46
316
1.48
1.71
2.5
2.0
ug/l
1.6
2.1
0.17
41
279
(3002582) Erythrocytes [#/volume] in Urine
285
2514
1.18
1.64
3.7
3.0
e6/l
20.6
91.6
1.94
228
1927
(3037121) Protein [Mass/volume] in Urine
39
262
1.51
1.63
2.9
3.0
g/l
0.3
0.3
0.04
11
105
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
28
174
1.63
1.62
1.1
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
28
174
1.63
1.62
1.1
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
229
1985
1.20
1.60
4.8
4.6
ug/l
2.2
2.4
0.24
202
1789
(21494890) Protein electrophoresis panel - 24 hour Urine
15
77
1.96
1.59
1.1
2.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
62
459
1.37
1.56
2.6
2.1
nmol/l
12.4
13.0
0.21
55
406
(3029937) Albumin [Presence] in Urine by Test strip
255
2237
1.19
1.56
4.8
4.0
estimate
0.0
0.0
0.27
67
754
(3018095) Leukocytes [#/volume] in Urine
331
2968
1.17
1.55
4.5
3.5
e6/l
52.0
114.9
1.44
247
2096
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
44
2.29
1.53
1.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
15
3.34
1.52
1.2
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
182
0.49
1.51
3.7
3.6
%
63.2
58.3
—
9
182
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
55
402
1.39
1.50
6.5
10.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
170
1.60
1.50
2.8
2.1
u/l
2536.1
1614.5
0.15
17
71
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
45
0.00
1.50
0.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
124
1.71
1.48
1.5
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
99
793
1.27
1.46
3.2
2.2
u/l
32.8
41.9
0.75
82
672
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
212
1.53
1.44
1.3
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
65
492
1.34
1.44
1.4
1.3
au/ml
37.0
34.1
—
7
26
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
16
3.13
1.44
1.6
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
16
3.13
1.44
1.4
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
74
573
1.31
1.41
1.6
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
85
671
1.29
1.41
1.9
2.7
e9/l
67.9
72.0
0.68
64
520
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
336
0.62
1.39
1.7
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
35
239
1.48
1.38
2.5
1.6
g/l
1.2
1.2
0.03
35
225
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
34
231
1.49
1.38
2.5
1.7
g/l
0.2
0.2
0.58
34
217
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
121
0.41
1.38
3.6
5.1
umol/l
280.6
352.3
—
5
104
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
41
2.21
1.37
1.3
2.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
23
2.62
1.37
1.5
1.1
g/l
0.3
0.3
—
6
18
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
71
550
1.31
1.36
2.7
2.5
au/ml
28.8
19.9
—
5
33
(40761536) Microorganisms panel - Urine sediment
55
727
0.74
1.35
4.6
3.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
39
0.00
1.34
0.0
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
42
2.15
1.34
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
81
642
1.28
1.32
1.8
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
106
1.71
1.30
1.3
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
174
0.51
1.30
3.7
3.4
e9/l
4.2
4.2
—
9
174
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
34
2.36
1.29
3.4
4.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(4094501)
35
244
1.45
1.27
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
26
170
1.54
1.27
4.1
1.7
nmol/l
0.8
0.8
0.32
21
137
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
146
1.59
1.26
1.4
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
154
1.57
1.26
1.2
1.2
u/l
11.8
12.4
0.05
19
124
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
34
236
1.46
1.26
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
163
1402
1.19
1.26
3.1
2.6
e6/l
1.0
1.2
0.20
105
780
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
36
2.23
1.24
2.6
2.8
u/ml
671.0
1204.5
—
8
36
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
37
262
1.43
1.24
2.1
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
12
63
1.92
1.23
1.3
1.3
%
41.7
28.6
—
7
37
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
355
3249
1.14
1.22
4.6
3.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
82
658
1.27
1.22
1.2
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
132
1.60
1.21
1.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
153
1314
1.19
1.20
3.3
2.7
e6/l
2.8
3.2
0.24
96
695
(3020779) Urea [Moles/volume] in Serum or Plasma
85
687
1.26
1.20
5.0
6.3
mmol/l
8.7
9.4
0.35
77
647
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
79
1.78
1.17
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
39
2.06
1.15
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
39
2.06
1.15
1.0
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
17
103
1.66
1.13
2.0
1.4
mu/l
141.7
38.9
0.54
17
96
(4062490)
13
73
1.79
1.11
1.7
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
53
408
1.32
1.10
1.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
66
1.83
1.09
1.2
2.0
—
—
—
0
0
(4015189)
5
21
2.39
1.09
1.0
2.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
128
1.57
1.09
2.2
1.8
—
—
—
0
0
(4027681)
8
41
1.96
1.09
1.1
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
196
1735
1.16
1.08
3.1
2.5
e6/l
4.5
6.6
1.83
177
1524
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
52
1.93
1.06
1.1
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
113
1.60
1.06
1.3
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
33
2.13
1.05
1.3
1.7
—
—
—
0
0
(1002224) Polysomnography panel
45
343
1.33
1.01
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
123
1.55
1.00
1.1
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
240
1.39
0.99
1.4
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
49
1.84
0.98
2.6
1.9
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
23
2.18
0.98
1.0
1.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
84
1.68
0.98
1.2
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
57
712
0.79
0.97
3.7
3.5
mmol/l
1.2
1.2
0.05
50
613
(3035320) C reactive protein [Mass/volume] in Body fluid
9
50
1.81
0.96
1.9
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
134
1164
1.17
0.95
1.5
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
158
1.47
0.94
1.3
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
65
527
1.25
0.93
3.5
3.2
pmol/l
4.5
4.5
0.10
55
457
(4035726)
65
795
0.81
0.93
1.3
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
37
279
1.34
0.91
11.8
3.7
mmol/l
1.2
1.4
1.27
37
272
(3005719) IgG [Mass/volume] in Serum or Plasma
74
613
1.22
0.88
3.2
2.9
g/l
9.9
10.7
1.06
69
555
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
493
0.76
0.88
1.6
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
21
144
1.47
0.87
4.2
2.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
136
1.48
0.87
1.5
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
44
1.82
0.86
1.9
3.4
—
—
—
0
0
(4024509)
12
72
1.67
0.85
1.3
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
13
80
1.63
0.85
3.2
5.1
u/ml
264.6
46.6
—
6
25
(3024891) Influenza virus A+B Ag [Presence] in Specimen
31
231
1.35
0.83
1.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
80
673
1.20
0.83
4.7
2.5
ml/min/173m2
62.1
65.2
0.35
35
285
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
27
197
1.38
0.82
1.4
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
22
155
1.43
0.81
1.7
1.3
mmol/l
41.6
58.5
2.33
17
128
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
215
1.36
0.81
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
130
1.47
0.81
1.9
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
8
47
1.71
0.80
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
128
1125
1.16
0.80
1.2
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
24
173
1.40
0.79
1.3
1.2
mmol/l
3.8
3.8
0.11
24
163
(21494755) Public health laboratory ask at order entry panel
62
746
0.82
0.78
1.2
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
359
1.27
0.77
1.5
1.8
g/l
1.7
1.6
0.40
38
313
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
177
1597
1.13
0.77
4.5
4.0
%
20.9
21.2
0.11
82
740
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
34
1.77
0.76
1.5
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
67
1.65
0.75
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
75
1.61
0.75
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
106
0.56
0.72
1.3
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
107
0.56
0.72
1.3
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
108
0.55
0.72
1.3
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
23
168
1.38
0.72
3.2
2.1
g/l
124.2
128.9
0.20
16
130
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
26
194
1.35
0.72
1.4
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
244
2253
1.11
0.71
3.7
2.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
58
482
1.22
0.71
1.5
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
265
1.29
0.70
1.3
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
41
1.71
0.70
1.9
3.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
85
1.54
0.69
1.2
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
100
875
1.16
0.69
3.6
4.0
u/l
240.8
243.1
0.07
95
825
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
77
1.57
0.68
1.3
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
27
1.86
0.68
2.0
2.7
%
137.8
112.9
—
5
27
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
62
732
0.84
0.67
1.8
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
34
269
1.27
0.64
1.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
129
1.40
0.63
1.2
1.1
u/ml
0.9
2.3
—
6
46
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
226
1.29
0.62
1.3
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(44806420)
0
21
0.00
0.60
0.0
2.4
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.4
—
10.4
—
0
16
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
114
1.41
0.59
1.0
1.0
u/ml
0.1
2.3
—
6
41
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
23
175
1.32
0.58
1.8
1.6
nmol/l
46.3
41.0
0.39
23
167
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
184
1.31
0.58
5.5
3.4
mg/l
36.4
22.2
0.75
15
112
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
35
1.72
0.57
1.3
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
54
1.49
0.57
4.3
6.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
132
1.37
0.57
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
132
1.37
0.57
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
265
1.25
0.57
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
36
1.67
0.56
1.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
86
0.58
0.56
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
65
1.54
0.55
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
228
0.74
0.55
1.4
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
23
177
1.31
0.55
4.0
3.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
60
1.50
0.54
1.1
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
63
1.43
0.52
1.4
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
397
3797
1.07
0.52
10.0
9.0
e9/l
0.0
0.0
0.51
329
3123
(40760892) CBC W Ordered Manual Differential panel - Blood
200
1866
1.09
0.49
3.9
4.5
—
—
—
0
0
(3036489) Thrombin time
25
312
0.80
0.49
2.0
1.8
s
20.9
21.2
0.22
20
278
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
45
1.56
0.49
1.0
1.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
18
234
0.77
0.48
4.0
2.1
%
181.9
187.5
0.07
18
223
(3050129) First trimester maternal screen panel - Serum or Plasma
11
155
0.71
0.48
1.2
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
78
692
1.14
0.48
6.4
7.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
119
1.35
0.48
1.0
1.0
u/ml
4.2
3.6
—
7
52
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
208
1.26
0.48
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
76
1.45
0.48
1.5
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
31
254
1.23
0.47
3.2
3.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
310
1.20
0.46
1.6
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
119
0.67
0.46
3.9
1.9
u/ml
3.8
37.4
—
8
114
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
50
1.40
0.45
1.4
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
85
763
1.12
0.45
3.3
3.1
kpa
6.0
5.8
0.85
80
743
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
69
1.45
0.44
1.5
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
69
1.45
0.44
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
176
1643
1.09
0.44
2.5
2.9
mmol/l
2.4
2.5
0.43
157
1455
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
129
0.70
0.43
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
129
0.70
0.43
1.3
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
130
0.69
0.43
1.3
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
130
0.69
0.43
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
78
1.41
0.43
1.4
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
5.4
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
56
1.43
0.42
1.5
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
32
1.57
0.42
1.8
3.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
33
1.52
0.41
1.0
1.3
nmol/l
133.6
156.0
—
5
33
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
71
635
1.13
0.41
5.0
4.3
%
0.0
0.1
1.11
18
153
(3028707) Methadone [Presence] in Urine by Screen method
11
79
1.40
0.41
1.6
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
79
1.40
0.41
1.5
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
23
186
1.24
0.40
1.7
3.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
34
1.47
0.40
1.0
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.0
—
23.5
—
0
18
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
160
0.75
0.40
2.3
2.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
101
0.69
0.39
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
97
1.34
0.39
1.2
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
7
106
0.66
0.39
1.3
1.3
nmol/l
0.3
0.3
—
7
83
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
19
0.00
0.39
0.0
1.0
—
27.0
—
0
14
(3030467) Casts [#/volume] in Urine by Automated count
244
2319
1.07
0.38
3.9
3.0
e6/l
0.3
0.5
2.03
193
1745
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
66
1.37
0.38
1.1
1.1
—
—
—
0
0
(4034850)
33
280
1.18
0.38
11.8
8.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
89
1.35
0.38
1.0
1.0
u/ml
4.9
3.0
—
5
34
(3020891) Body temperature
37
318
1.17
0.37
13.2
4.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
37
1.35
0.37
1.2
1.5
—
—
—
0
0
(4211845)
5
37
1.35
0.37
1.8
3.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
37
1.35
0.37
1.2
1.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
5
37
1.35
0.37
1.0
1.0
—
0.4
—
0
9
(3041096) Erythrocytes [Presence] in Urine by Automated
241
2295
1.07
0.36
3.4
3.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
135
0.74
0.36
1.3
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
82
899
0.90
0.36
3.8
3.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
126
1172
1.09
0.35
2.9
2.9
ug/l
0.6
0.8
1.04
81
758
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
126
1.27
0.35
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
213
2240
0.94
0.35
1.3
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
45
1.34
0.33
1.3
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
45
1.34
0.33
3.7
3.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
45
1.34
0.33
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
118
1.28
0.33
1.5
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
87
0.69
0.33
4.7
3.0
%
13.5
13.1
—
6
87
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
46
1.31
0.33
2.3
2.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
1.5
1.3
—
60.9
—
0
16
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
224
2347
0.94
0.33
1.7
1.6
mmol/l
1.5
1.4
0.96
192
1959
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
45
398
1.14
0.32
3.0
3.1
mmol/l
24.2
24.1
0.08
38
362
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
74
1.35
0.32
1.9
2.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
143
0.77
0.32
1.5
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
99
0.71
0.30
1.4
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
93
1.29
0.30
2.6
3.8
—
—
—
0
0
(44813793)
7
55
1.27
0.30
1.3
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
82
757
1.09
0.29
3.3
3.1
mmol/l
1.9
1.9
0.07
73
618
(3022806) Fractional oxyhemoglobin in Capillary blood
8
108
0.74
0.29
1.6
1.9
%
92.0
89.3
—
8
108
(3024928) Oxygen saturation in Venous blood
23
195
1.18
0.28
2.1
2.3
—
—
—
0
0
(3026782) Osmolality of Urine
174
1657
1.06
0.27
3.0
2.7
mosm/kgh2o
526.8
538.9
0.30
151
1413
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
150
0.80
0.27
1.2
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
60
655
0.91
0.26
4.8
4.0
%
1.6
0.6
0.35
16
144
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
150
1.20
0.26
1.5
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
178
1.18
0.26
1.3
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
71
0.70
0.26
1.0
1.6
%
10.1
10.6
—
5
71
(3019230) Fractional oxyhemoglobin in Venous blood
13
160
0.81
0.26
1.2
2.0
%
56.2
59.8
0.21
13
160
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
72
1.25
0.25
1.7
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
73
1.23
0.25
1.3
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
73
1.23
0.25
1.4
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
73
676
1.09
0.25
5.2
4.2
%
0.1
0.1
0.09
21
183
(3025130) Human papilloma virus identified in Specimen
12
96
1.25
0.24
1.3
2.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
77
716
1.08
0.24
5.2
4.1
%
0.6
1.0
0.88
22
205
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
30
266
1.13
0.23
1.3
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
88
1.25
0.22
1.7
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
5
42
1.19
0.21
1.0
1.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
5.5
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.6
—
3.8
—
0
5
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.4
—
50.0
—
0
10
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
26
230
1.13
0.20
1.8
1.8
iu/l
1.9
5.4
—
8
77
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
35
317
1.11
0.20
2.1
1.7
mg/l
3.0
4.7
0.40
29
237
(3014576) Chloride [Moles/volume] in Serum or Plasma
108
1028
1.06
0.19
9.0
6.4
mmol/l
104.7
104.2
0.85
103
1002
(3035637) Corticotropin [Mass/volume] in Plasma
10
81
1.24
0.18
2.1
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
119
1.18
0.17
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
96
914
1.06
0.17
1.7
1.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
5
67
0.75
0.17
1.4
1.3
mmol/l
6.1
7.1
—
5
61
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
70
0.71
0.16
2.2
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
72
1.11
0.16
1.4
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
130
0.84
0.16
1.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
111
1.17
0.15
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
78
0.77
0.15
1.7
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
121
1.16
0.15
1.0
1.0
—
—
—
0
0
(4306422)
14
121
1.16
0.15
1.1
1.2
—
—
—
0
0
(4268621)
9
82
1.10
0.15
2.1
2.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
11
129
0.85
0.14
1.7
1.8
mmol/l
1.4
1.7
0.49
11
129
(3004809) Band form neutrophils/100 leukocytes in Blood
14
122
1.15
0.13
3.7
3.5
%
0.9
1.8
—
9
99
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
97
0.82
0.13
1.4
2.1
pg
33.3
32.2
—
8
97
(1617658) Protocol used for examination of sentinel lymph nodes
8
97
0.82
0.13
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
151
1.13
0.13
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
85
1.18
0.12
4.5
4.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
19
210
0.90
0.12
1.5
1.3
miu/ml
286.9
254.4
0.16
13
89
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
424
1.06
0.12
1.4
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
15
133
1.13
0.12
1.9
1.8
pmol/l
151.8
221.9
1.87
15
126
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
116
0.86
0.12
1.6
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
96
927
1.04
0.11
2.9
4.4
ug/l
8.2
24.3
0.99
77
753
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
250
1.08
0.11
2.1
2.6
u/ml
0.3
0.4
0.28
13
141
(40768793) Breast Pathology biopsy report
27
250
1.08
0.11
1.3
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
86
1.16
0.11
1.3
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
146
1498
0.97
0.11
1.4
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
134
1.12
0.11
1.6
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
57
544
1.05
0.10
1.4
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.6
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.6
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.6
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.6
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
43
452
0.95
0.09
1.5
1.8
—
—
—
0
0
(3000492) Spirometry study
80
777
1.03
0.07
1.7
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
75
0.80
0.07
1.5
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
618
6143
1.01
0.07
4.1
3.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
77
1.04
0.07
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
77
1.04
0.07
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
77
1.04
0.07
1.5
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
83
0.84
0.07
1.3
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
122
0.90
0.07
2.5
2.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
94
0.85
0.06
4.1
3.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
132
0.91
0.06
1.2
1.0
—
14.5
—
0
8
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
104
0.86
0.06
1.4
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
716
7130
1.01
0.06
21.2
16.5
%
13.8
13.7
0.47
707
6965
(3027944) Amphetamines [Presence] in Urine
19
202
0.94
0.05
1.5
1.4
—
—
—
0
0
(4281824)
11
120
0.92
0.05
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
22
231
0.95
0.04
2.6
4.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
190
1.05
0.04
1.5
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
179
0.95
0.03
1.9
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
148
0.95
0.02
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
21
203
1.04
0.01
1.5
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
21
203
1.04
0.01
1.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
21
203
1.04
0.01
1.5
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
114
1.05
0.00
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
124
1.05
0.00
1.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
19
184
1.03
0.00
1.5
1.4
—
—
—
0
0
(3010421) pH of Blood
23
236
0.97
0.00
3.1
3.8
ph
7.4
7.4
0.06
17
179
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
144
0.97
0.00
1.5
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
128
1.02
0.00
1.3
1.2
u/ml
8.4
5.4
—
7
48
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
138
1.01
0.00
1.4
1.2
u/ml
219.5
234.2
—
8
82
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
199
1.01
0.00
2.0
2.3
ug/min
20.6
88.9
2.02
12
118
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
139
1.01
0.00
1.5
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
105
1.05
0.00
2.5
2.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
10.5
—
0
7
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
83
0.96
0.00
1.5
1.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
89
1.01
0.00
1.7
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
7.8
—
0
5
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
6.0
—
6.2
—
0
7
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
50
1.00
0.00
2.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
14.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
51
0.98
0.00
2.0
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
91
0.99
0.00
1.4
1.7
—
—
—
0
0
(3025315) Body weight
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
32.8
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint G6_MONOLOWOTHUNS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MONOLOWOTHUNS | 1.054 [0.91, 1.22] | 0.49 |
| Birth year | 0.998 [0.99, 1.01] | 0.682 |
During the follow-up period (1.1.1998 — 31.12.2019), 254 out of 2459 females with G6_MONOLOWOTHUNS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MONOLOWOTHUNS | 1.209 [1.02, 1.44] | 0.03 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 237 out of 1432 males with G6_MONOLOWOTHUNS died.
Mortality risk
Mortality risk for people of age
years, who have G6_MONOLOWOTHUNS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.109% | 0.254% |
| 5 | 0.697% | 1.393% |
| 10 | 1.702% | 3.453% |
| 15 | 3.286% | 6.648% |
| 20 | 5.71% | 10.85% |
Relationships between endpoints
↥Index endpoint: G6_MONOLOWOTHUNS – Other and unspecified mononeuropathies of lower limb
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data